These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

785 related articles for article (PubMed ID: 26912814)

  • 1. Potassium Channel Subfamily K Member 3 (KCNK3) Contributes to the Development of Pulmonary Arterial Hypertension.
    Antigny F; Hautefort A; Meloche J; Belacel-Ouari M; Manoury B; Rucker-Martin C; Péchoux C; Potus F; Nadeau V; Tremblay E; Ruffenach G; Bourgeois A; Dorfmüller P; Breuils-Bonnet S; Fadel E; Ranchoux B; Jourdon P; Girerd B; Montani D; Provencher S; Bonnet S; Simonneau G; Humbert M; Perros F
    Circulation; 2016 Apr; 133(14):1371-85. PubMed ID: 26912814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of KCNK3 is a hallmark of RV hypertrophy/dysfunction associated with pulmonary hypertension.
    Lambert M; Boet A; Rucker-Martin C; Mendes-Ferreira P; Capuano V; Hatem S; Adão R; Brás-Silva C; Hautefort A; Michel JB; Dorfmuller P; Fadel E; Kotsimbos T; Price L; Jourdon P; Montani D; Humbert M; Perros F; Antigny F
    Cardiovasc Res; 2018 May; 114(6):880-893. PubMed ID: 29360952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of
    Lambert M; Capuano V; Boet A; Tesson L; Bertero T; Nakhleh MK; Remy S; Anegon I; Pechoux C; Hautefort A; Rucker-Martin C; Manoury B; Domergue V; Mercier O; Girerd B; Montani D; Perros F; Humbert M; Antigny F
    Circ Res; 2019 Sep; 125(7):678-695. PubMed ID: 31347976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Impact of Heterozygous
    Bohnen MS; Roman-Campos D; Terrenoire C; Jnani J; Sampson KJ; Chung WK; Kass RS
    J Am Heart Assoc; 2017 Sep; 6(9):. PubMed ID: 28889099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dichloroacetate prevents and reverses pulmonary hypertension by inducing pulmonary artery smooth muscle cell apoptosis.
    McMurtry MS; Bonnet S; Wu X; Dyck JR; Haromy A; Hashimoto K; Michelakis ED
    Circ Res; 2004 Oct; 95(8):830-40. PubMed ID: 15375007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo miR-138-5p inhibition alleviates monocrotaline-induced pulmonary hypertension and normalizes pulmonary KCNK3 and SLC45A3 expression.
    Le Ribeuz H; Courboulin A; Ghigna MR; Lambert M; Hautefort A; Humbert M; Montani D; Cohen-Kaminsky S; Perros F; Antigny F
    Respir Res; 2020 Jul; 21(1):186. PubMed ID: 32678044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bmpr2 Mutant Rats Develop Pulmonary and Cardiac Characteristics of Pulmonary Arterial Hypertension.
    Hautefort A; Mendes-Ferreira P; Sabourin J; Manaud G; Bertero T; Rucker-Martin C; Riou M; Adão R; Manoury B; Lambert M; Boet A; Lecerf F; Domergue V; Brás-Silva C; Gomez AM; Montani D; Girerd B; Humbert M; Antigny F; Perros F
    Circulation; 2019 Feb; 139(7):932-948. PubMed ID: 30586714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Let-7a-transfected mesenchymal stem cells ameliorate monocrotaline-induced pulmonary hypertension by suppressing pulmonary artery smooth muscle cell growth through STAT3-BMPR2 signaling.
    Cheng G; Wang X; Li Y; He L
    Stem Cell Res Ther; 2017 Feb; 8(1):34. PubMed ID: 28187784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crosstalk between BMP signaling and KCNK3 in phenotypic switching of pulmonary vascular smooth muscle cells.
    Yeo Y; Jeong H; Kim M; Choi Y; Kim KL; Suh W
    BMB Rep; 2022 Nov; 55(11):565-570. PubMed ID: 36016502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of KCNK3 Dysfunction in Dasatinib-associated Pulmonary Arterial Hypertension and Endothelial Cell Dysfunction.
    Ribeuz HL; Willer AS; Chevalier B; Sancho M; Masson B; Eyries M; Jung V; Guerrera IC; Dutheil M; Jekmek KE; Laubry L; Carpentier G; Perez-Vizcaino F; Tu L; Guignabert C; Chaumais MC; Péchoux C; Humbert M; Hinzpeter A; Mercier O; Capuano V; Montani D; Antigny F
    Am J Respir Cell Mol Biol; 2024 Jul; 71(1):95-109. PubMed ID: 38546978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KCNK3: new gene target for pulmonary hypertension?
    Girerd B; Perros F; Antigny F; Humbert M; Montani D
    Expert Rev Respir Med; 2014 Aug; 8(4):385-7. PubMed ID: 24742047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of FGFR Signaling With PD173074 Ameliorates Monocrotaline-induced Pulmonary Arterial Hypertension and Rescues BMPR-II Expression.
    Zheng Y; Ma H; Hu E; Huang Z; Cheng X; Xiong C
    J Cardiovasc Pharmacol; 2015 Nov; 66(5):504-14. PubMed ID: 26535780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kcnk3 dysfunction exaggerates the development of pulmonary hypertension induced by left ventricular pressure overload.
    Lambert M; Mendes-Ferreira P; Ghigna MR; LeRibeuz H; Adão R; Boet A; Capuano V; Rucker-Martin C; Brás-Silva C; Quarck R; Domergue V; Vachiéry JL; Humbert M; Perros F; Montani D; Antigny F
    Cardiovasc Res; 2021 Nov; 117(12):2474-2488. PubMed ID: 33483721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Receptor for activated C-kinase 1, a novel interaction partner of type II bone morphogenetic protein receptor, regulates smooth muscle cell proliferation in pulmonary arterial hypertension.
    Zakrzewicz A; Hecker M; Marsh LM; Kwapiszewska G; Nejman B; Long L; Seeger W; Schermuly RT; Morrell NW; Morty RE; Eickelberg O
    Circulation; 2007 Jun; 115(23):2957-68. PubMed ID: 17515463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nebivolol for improving endothelial dysfunction, pulmonary vascular remodeling, and right heart function in pulmonary hypertension.
    Perros F; Ranchoux B; Izikki M; Bentebbal S; Happé C; Antigny F; Jourdon P; Dorfmüller P; Lecerf F; Fadel E; Simonneau G; Humbert M; Bogaard HJ; Eddahibi S
    J Am Coll Cardiol; 2015 Feb; 65(7):668-80. PubMed ID: 25677428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysyl oxidases play a causal role in vascular remodeling in clinical and experimental pulmonary arterial hypertension.
    Nave AH; Mižíková I; Niess G; Steenbock H; Reichenberger F; Talavera ML; Veit F; Herold S; Mayer K; Vadász I; Weissmann N; Seeger W; Brinckmann J; Morty RE
    Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1446-58. PubMed ID: 24833797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deficiency of NOX1/nicotinamide adenine dinucleotide phosphate, reduced form oxidase leads to pulmonary vascular remodeling.
    Iwata K; Ikami K; Matsuno K; Yamashita T; Shiba D; Ibi M; Matsumoto M; Katsuyama M; Cui W; Zhang J; Zhu K; Takei N; Kokai Y; Ohneda O; Yokoyama T; Yabe-Nishimura C
    Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):110-9. PubMed ID: 24233492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization and regulation of wild-type and mutant TASK-1 two pore domain potassium channels indicated in pulmonary arterial hypertension.
    Cunningham KP; Holden RG; Escribano-Subias PM; Cogolludo A; Veale EL; Mathie A
    J Physiol; 2019 Feb; 597(4):1087-1101. PubMed ID: 30365877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum-glucocorticoid regulated kinase 1 regulates macrophage recruitment and activation contributing to monocrotaline-induced pulmonary arterial hypertension.
    Xi X; Liu S; Shi H; Yang M; Qi Y; Wang J; Du J
    Cardiovasc Toxicol; 2014 Dec; 14(4):368-78. PubMed ID: 24825325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New molecular targets of pulmonary vascular remodeling in pulmonary arterial hypertension: importance of endothelial communication.
    Guignabert C; Tu L; Girerd B; Ricard N; Huertas A; Montani D; Humbert M
    Chest; 2015 Feb; 147(2):529-537. PubMed ID: 25644906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.